As the ranking member of the House Intelligence Committee, Devin Nunes has recently been in the spotlight for his pro-Trump support during recent impeachment inquiry hearings. But like all members of Congress, he has an election coming up in 2020 and his Democrat challenger says his campaign has seen an outpouring of support since the hearings began.

"We've received over $300,000 in contributions since the beginning of this impeachment hearing from over 10,000 individual contributions," said Phil Arballo, who is trying to win the seat for California's 22nd District — a seat which Nunes has held since 2003.

Arballo, a Mexican-American businessman, entered the Democratic primary for the seat in June but said his campaign has seen a "groundswell of support" since attention shifted to Nunes during the hearings last week.

"As a constituent of his, and I can tell you from talking to a lot of people every day here on the ground, it's embarrassing, that he's our representative, here. He does not represent us here," Arballo said of the Central Valley.

Nunes defeated his Democratic challenger in 2018, but Arballo thinks the tide will turn in 2020.

"It's a very winnable seat," he said. "Everything is trending in the right direction for our race next year."

Nunes is not the only Republican whose role in the hearings may be helping Democratic challengers. Rep. Elise Stefanik of New York's 21st Congressional District played a prominent role in the hearings. Her 2020 challenger Tedra Cobb, who unsuccessfully challenged Stefanik in 2018, announced her campaign raised $1 million the weekend after the impeachment hearings.

Share:
More In Politics
Cresco Labs Unveils Sunnyside Cannabis Retail Concept
Chicago-based cannabis company Cresco Labs unveiled a new dispensary and retail cannabis shop concept on Monday. Called Sunnyside, the concept emphasizes health and wellness and aims to create an accessible, immersive retail environment that pushes Cresco along on its mission of creating a nationally-recognizable cannabis brand.
CannTrust Stock Jumps After CEO Ouster
Shares of CannTrust surged 15 percent on Friday after the Canadian cannabis company announced it terminated CEO Peter Aceto in the midst of regulatory drama that has plundered the company's stock value. Jefferies' analyst Ryan Tomkins predicted the management shuffle in a Wednesday note, which called management's positions "untenable."
Robert Mueller Confirms Trump Was 'Not Exculpated' in Russia Investigation
With all eyes on Capitol Hill on Wednesday, former Special Counsel Robert Mueller began his much-anticipated testimony by largely repeating what he outlined in April in his report on Russian interference in the 2016 election, - but stating very clearly that in the investigation, “the president was not exculpated for the acts that he allegedly committed.”
Load More